ARS Pharmaceuticals - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeARS Pharmaceuticals
ARS Pharmaceuticals logo

ARS Pharmaceuticals

0 followers

SPRY

Performance

About ARS Pharmaceuticals

ARS Pharmaceuticals is focused on enhancing safety for individuals at risk of severe allergic reactions through innovative solutions. They are developing ARS-1, an intranasal epinephrine spray designed for comfort and reliability, aimed at providing an easier and more effective way for patients and caregivers to manage anaphylaxis due to food, medications, and insect stings.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Richard Lowenthal

President and Chief Executive Officer

Sarina Tanimoto

Chief Medical Officer

Brian T. Dorsey

Chief Operating Officer

Alexander A. Fitzpatrick

Chief Legal Officer

Eric Karas

Chief Commercial Officer

Key Facts

HQ Location

San Diego, United States

Founded

2015

Employees

51 - 200

Status

Public

Website

https://ars-pharma.com